FourThought Financial Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-9,572
Closed -$462K – 523
2025
Q2
$462K Buy
9,572
+2,136
+29% +$109K 0.05% 193
2025
Q1
$412K Buy
7,436
+306
+4% +$16.6K 0.04% 202
2024
Q4
$344K Sell
7,130
-461
-6% -$23.4K 0.04% 231
2024
Q3
$437K Buy
7,591
+51
+0.7% +$2.75K 0.05% 145
2024
Q2
$366K Buy
7,540
+86
+1% +$4.15K 0.05% 155
2024
Q1
$362K Buy
7,454
+2,338
+46% +$114K 0.04% 231
2023
Q4
$254K Sell
5,116
-20
-0.4% -$978 0.03% 271
2023
Q3
$276K Sell
5,136
-9
-0.2% -$480 0.04% 245
2023
Q2
$277K Sell
5,145
-746
-13% -$40.1K 0.04% 262
2023
Q1
$321K Buy
5,891
+90
+2% +$4.38K 0.04% 238
2022
Q4
$281K Buy
+5,801
New +$255K 0.04% 264

Other funds holding SNY

FourThought Financial Partners's SNY Position: Q3 2025 in Review

FourThought Financial Partners sold out of Sanofi (SNY) in Q3 2025, closing a stake of 9,572 shares — an estimated $462K sold.

FourThought Financial Partners first reported a position in SNY in Q4 2022 and held it in 11 quarters. The position peaked at $462K in Q2 2025. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • FourThought Financial Partners reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • FourThought Financial Partners sold 9,572 Sanofi shares in Q3 2025, an estimated $462K.
  • FourThought Financial Partners first reported a position in Sanofi in Q4 2022 and held it in 11 quarters.
  • FourThought Financial Partners's Sanofi position peaked at $462K in Q2 2025.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on FourThought Financial Partners's 13F filing for Q3 2025, filed 13 Nov 2025.